Tacrolimus sustained-release capsule
BJ309CT-02
Approved small_molecule completed
Quick answer
Tacrolimus sustained-release capsule for Renal Transplant Recipients is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Renal Transplant Recipients
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed